                               SEQUENCE LISTING

<110> PROTIVA BIOTHERAPEUTICS, INC.
 
<120> COMPOSITIONS AND METHODS FOR SILENCING EBOLA VIRUS EXPRESSION

<130> 08155.037WO1

<140> PCT/IB2015/058539
<141> 2015-11-05

<150> 62/076,937
<151> 2014-11-07

<160> 8     

<170> PatentIn version 3.5

<210> 1
<211> 21
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 1
gcaauucauu ggacauuauu c                                                 21


<210> 2
<211> 21
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 2
auaaugucca augaauugcu a                                                 21


<210> 3
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<220>
<223> Description of Combined DNA/RNA Molecule: Synthetic
      oligonucleotide

<400> 3
guacgaagcu guacauaaat t                                                 21


<210> 4
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<220>
<223> Description of Combined DNA/RNA Molecule: Synthetic
      oligonucleotide

<400> 4
uuuauguaca gcuucguact t                                                 21


<210> 5
<211> 21
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<221> modified_base
<222> (1)..(1)
<223> 2'O-methyl modified nucleotide

<220>
<221> modified_base
<222> (6)..(6)
<223> 2'O-methyl modified nucleotide

<220>
<221> modified_base
<222> (10)..(10)
<223> 2'O-methyl modified nucleotide

<220>
<221> modified_base
<222> (12)..(12)
<223> 2'O-methyl modified nucleotide

<220>
<221> modified_base
<222> (16)..(16)
<223> 2'O-methyl modified nucleotide

<220>
<221> modified_base
<222> (19)..(20)
<223> 2'O-methyl modified nucleotide

<400> 5
gcaauucauu ggacauuauu c                                                 21


<210> 6
<211> 21
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<221> modified_base
<222> (2)..(2)
<223> 2'O-methyl modified nucleotide

<220>
<221> modified_base
<222> (6)..(6)
<223> 2'O-methyl modified nucleotide

<220>
<221> modified_base
<222> (17)..(17)
<223> 2'O-methyl modified nucleotide

<220>
<221> modified_base
<222> (20)..(20)
<223> 2'O-methyl modified nucleotide

<400> 6
auaaugucca augaauugcu a                                                 21


<210> 7
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<220>
<223> Description of Combined DNA/RNA Molecule: Synthetic
      oligonucleotide


<220>
<221> modified_base
<222> (2)..(2)
<223> 2'O-methyl modified nucleotide

<220>
<221> modified_base
<222> (5)..(5)
<223> 2'O-methyl modified nucleotide

<220>
<221> modified_base
<222> (10)..(12)
<223> 2'O-methyl modified nucleotide

<220>
<221> modified_base
<222> (14)..(14)
<223> 2'O-methyl modified nucleotide

<220>
<221> modified_base
<222> (16)..(16)
<223> 2'O-methyl modified nucleotide

<400> 7
guacgaagcu guacauaaat t                                                 21


<210> 8
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<220>
<223> Description of Combined DNA/RNA Molecule: Synthetic
      oligonucleotide


<220>
<221> modified_base
<222> (5)..(5)
<223> 2'O-methyl modified nucleotide

<220>
<221> modified_base
<222> (13)..(13)
<223> 2'O-methyl modified nucleotide

<220>
<221> modified_base
<222> (17)..(17)
<223> 2'O-methyl modified nucleotide

<400> 8
uuuauguaca gcuucguact t                                                 21


